Head-to-head · WeighScore
NowPatient vs Valhalla Vitality
The verdict
NowPatient takes it — 65.5/100 to 63.6/100, but only just.
NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda. Valhalla Vitality is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NowPatient | Valhalla Vitality |
|---|---|---|
| WeighScore | 65.5/100 | 63.6/100 |
| Grade | C | C |
| Scorecard rank | #217 | #253 |
| Semaglutide | $1,349/mo (brand Wegovy) | $449/mo (compounded) |
| Tirzepatide | $1,069/mo (brand Mounjaro, promotional rate) | $449/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #217 · C
Strengths
- Free telehealth consultation — you only pay for the medication
- Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
- One of the few platforms offering Wegovy in both injection and oral pill form
- No compounded options — every drug is FDA-approved brand-name
Where it loses points
- Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
- No compounded semaglutide or tirzepatide (usually the cheaper route)
- State availability determined during intake, not shown upfront
- Does not offer Foundayo (orforglipron)
Graded #253 · C
Strengths
- LegitScript-certified pharmacy partner
- Offers both compounded semaglutide and tirzepatide
- No membership fees and free consultations
- Add-on peptide and hormone therapies plus at-home labs
Where it loses points
- Compounded GLP-1 only, no FDA-approved branded options
- Pricing not transparently listed on the main site
- Compounded drugs are not FDA-approved for safety or efficacy
- States served not clearly disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.